Venus Remedies gets Rs 11.78 crore PLI incentive from government

Business Updates View source PDF Explain this filing

VENUSREM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.8%Reaction day

₹733.95

prior close

₹742.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.6%-0.7% vs market

Pharmaceuticals peers, median of 156sector+1.2%-0.4% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.8+1.6-0.7+1.2-0.4

Next day

-0.8-0.6-0.2+0.0-0.8

+2.0-0.5+2.5-0.7+2.7

+2.3+1.5+0.8+0.2+2.1

+6.5+1.1+5.4-0.3+6.9

+11.8+3.0+8.8+0.1+11.7

+8.3+5.5+2.8+2.4+5.9

15d

+1.9+6.1-4.2+2.7-0.8

+2.2+5.1-2.9+1.2+0.9

+12.4-8.0+20.4-8.5+20.9

+43.5+10.9+32.6+3.4+40.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Venus Remedies has been awarded Rs 11.78 crore (Rs 11,77,50,000) under the government's Production Linked Incentive (PLI) scheme for pharmaceutical manufacturing. This is the second disbursement under the scheme, with Rs 10 crore already received earlier. The incentive supports the company's commitment to innovation and operational excellence in pharma manufacturing.

Likely market impact

Positive cash inflow from government incentive rewards manufacturing performance and strengthens margins. Reinforces operational track record.